[HTML][HTML] Population pharmacokinetic evaluation of ADV6209, an innovative oral solution of midazolam containing cyclodextrin
F Marçon, C Guittet, MA Manso, I Burton… - European Journal of …, 2018 - Elsevier
Introduction In the absence of a licensed formulation in many countries worldwide,
ADV6209, an innovative 2 mg/ml oral solution of midazolam containing cyclodextrin, has …
ADV6209, an innovative 2 mg/ml oral solution of midazolam containing cyclodextrin, has …
Population pharmacokinetic evaluation of ADV6209, an innovative oral solution of midazolam containing cyclodextrin.
F Marçon, C Guittet, MA Manso, I Burton… - European Journal of …, 2017 - europepmc.org
In the absence of a licensed formulation in many countries worldwide, ADV6209, an
innovative 2mg/ml oral solution of midazolam containing cyclodextrin, has been developed …
innovative 2mg/ml oral solution of midazolam containing cyclodextrin, has been developed …
Population pharmacokinetic evaluation of ADV6209, an innovative oral solution of midazolam containing cyclodextrin
F Marçon, C Guittet, MA Manso… - … : official journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Introduction In the absence of a licensed formulation in many countries worldwide,
ADV6209, an innovative 2mg/ml oral solution of midazolam containing cyclodextrin, has …
ADV6209, an innovative 2mg/ml oral solution of midazolam containing cyclodextrin, has …
[PDF][PDF] Population pharmacokinetic evaluation of ADV6209, an innovative oral solution of midazolam containing cyclodextrin
F Marçon, C Guittet, MA Manso, I Burton… - European Journal of …, 2018 - researchgate.net
Introduction: In the absence of a licensed formulation in many countries worldwide,
ADV6209, an innovative 2 mg/ml oral solution of midazolam containing cyclodextrin, has …
ADV6209, an innovative 2 mg/ml oral solution of midazolam containing cyclodextrin, has …
Population pharmacokinetic evaluation of ADV6209, an innovative oral solution of midazolam containing cyclodextrin
J Li, SF Xu, N Wang, CC Guittet, MA Manso… - European Journal of …, 2018 - hero.epa.gov
In the absence of a licensed formulation in many countries worldwide, ADV6209, an
innovative 2mg/ml oral solution of midazolam containing cyclodextrin, has been developed …
innovative 2mg/ml oral solution of midazolam containing cyclodextrin, has been developed …
Population pharmacokinetic evaluation of ADV6209, an innovative oral solution of midazolam containing cyclodextrin
F Marcon, C Guittet, MA Manso, I Burton… - European Journal of …, 2018 - hal.science
Introduction: In the absence of a licensed formulation in many countries worldwide,
ADV6209, an innovative 2 mg/ml oral solution of midazolam containing cyclodextrin, has …
ADV6209, an innovative 2 mg/ml oral solution of midazolam containing cyclodextrin, has …
Population pharmacokinetic evaluation of ADV6209, an innovative oral solution of midazolam containing cyclodextrin
F Marcon, C Guittet, MA Manso… - European Journal …, 2018 - u-picardie.hal.science
Introduction: In the absence of a licensed formulation in many countries worldwide,
ADV6209, an innovative 2 mg/ml oral solution of midazolam containing cyclodextrin, has …
ADV6209, an innovative 2 mg/ml oral solution of midazolam containing cyclodextrin, has …